Asthma

Biotech Blogs

Chiesi on Sustainability in Asthma and COPD R&D
Life Science Podcast

Sustainability in Asthma and COPD Drug Development with Chiesi’s Diego Ardigò — Episode 259
Biotech Blogs

World Asthma Day 2026: New Anti-Inflammatory Drugs and More for Asthma Control
Biotech Blogs

Designing Clinical Trials to Address Asthma and COPD Flare-Ups
Biotech News

Generate Biomedicines IPO Raises $400M with Phase III Asthma Therapy in Pipeline
Approvals News

New Ultra-Long-Acting Biologic, Exdensur (Depemokimab), Approved for Asthma
Life Science Podcast

The Evolving Landscape of Respiratory and Immunology Drug Development with AstraZeneca’s Dr. Andrew Menzies-Gow — Episode 234
Biotech Blogs

Top 5 Best-Selling Respiratory Disease Drugs to Watch in 2025
Biotech Blogs

Advancing Asthma Management Through Innovation, Access and Equity
Life Science Podcast

Targeting Mast Cells: A New Frontier in Allergy & Inflammation with Jasper Therapeutics’ CMO Dr. Edwin Tucker — Episode 214
Biotech Blogs

World Asthma Day 2025: Make Inhaled Treatments Accessible for ALL
Approvals News

Omlyclo Becomes First Biosimilar to Rival Xolair
Biotech Blogs

Nasal Delivery of mRNA Therapeutics: A Novel Approach to Drug Development for Asthma
Life Science Podcast

Pioneering mRNA Therapies for Lung Diseases
Business & Finance News

Senator Maggie Hassan Blasts GSK for Discontinuing Common Children’s Asthma Inhaler to Dodge Price Cap
Blogs

World Asthma Day 2024: Innovations in Asthma Care